A down-regulation of cannabinoid receptor 1 (CBR1), associated with an increased expression of nucleobindin 1 (NUCB1) protein in the temporal cortical neurons, might be responsible for the comorbid mood disorder in the above-mentioned study. The gene discussed is CBR1; the disease is mood disorder.